☾ Luna users · clinical trials
The participant companion as a trial-management sensor: consent, engagement, mood, and escalations per participant. Severe symptoms, crisis language, and withdrawal talk from Luna land in the review queue; stale check-ins and low mood feed the dropout-risk score.
Participants on Luna
4
Consent granted
3
Active today
3
Fleet mood ø
3.0
Escalations
2
Stale check-ins
0
| Participant | Study / patient | Consent | Msgs | Check-ins | Mood ø | Esc. | Engagement |
|---|---|---|---|---|---|---|---|
|
MO
|
GAL-001: Adaptive Phase II in Refractory Melanoma
GAL001-001 · enrolled
|
granted | 4 | 1 |
4.0
|
0 |
active today
last check-in 2026-08-18
|
|
JR
|
GAL-001: Adaptive Phase II in Refractory Melanoma
GAL001-002 · enrolled
|
granted | 2 | 2 |
2.0
|
2 |
active today
last check-in 2026-08-18
|
|
ED
|
GAL-001: Adaptive Phase II in Refractory Melanoma
GAL001-004 · enrolled
|
granted | 4 | 1 |
3.0
|
0 |
active today
last check-in 2026-08-18
|
|
SW
|
GAL-001: Adaptive Phase II in Refractory Melanoma
GAL001-005 · consented
|
pending | 0 | 0 | – | 0 |
active never
last check-in —
|
☾
Select a participant to see their Luna transcript and check-in history.